Vivos Therapeutics, Inc. (VVOS) › Operating Cash FlowVivos Therapeutics, Inc. (VVOS) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$5.34M2020: -$5.68M2021: -$15.73M2022: -$19.59M2023: -$11.95M2024: -$12.69M2025: -$15.26M-$15.26M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$15.26M-20.3%2024-$12.69M-6.2%2023-$11.95M+39.0%2022-$19.59M-24.5%2021-$15.73M-177.0%2020-$5.68M-6.4%2019-$5.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share